New left ventricular microlead technology to improve cardiac resynchronization therapy implant outcomes Posted on August 14th, 2023 by LEADconnection Post navigation Previous: Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry.Next: Experience with implantation of Select Secure® leads in paediatric patients.
Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry. Posted on August 14th, 2023 by LEADconnection Post navigation Previous: Implant efficiency and clinical performance of Aveir™ VR and Micra™ VR leadless pacemaker: A multicenter comparative analysis of 67 patientsNext: New left ventricular microlead technology to improve cardiac resynchronization therapy implant outcomes
Implant efficiency and clinical performance of Aveir™ VR and Micra™ VR leadless pacemaker: A multicenter comparative analysis of 67 patients Posted on August 14th, 2023 by LEADconnection Post navigation Previous: Efficacy and mortality of rotating sheaths versus laser sheaths for transvenous lead extraction: a meta-analysisNext: Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry.
